4.7 Article

β1 integrins mediate resistance to ionizing radiation in vivo by inhibiting c-Jun amino terminal kinase 1

期刊

JOURNAL OF CELLULAR PHYSIOLOGY
卷 228, 期 7, 页码 1601-1609

出版社

WILEY
DOI: 10.1002/jcp.24323

关键词

-

资金

  1. NIH [R01 CA89720, CA-109874, P01 CA-140043, R01 CA-65861, R01 CA-164462]
  2. Diabetes Endocrinology Research Center [DK32520]
  3. ACS (ACS Institutional Research Grant) [IRG-93-033]
  4. Pennsylvania Department of Health
  5. Commonwealth University Research Enhancement Program

向作者/读者索取更多资源

This study was carried out to dissect the mechanism by which 1 integrins promote resistance to radiation. For this purpose, we conditionally ablated 1 integrins in the prostatic epithelium of transgenic adenocarcinoma of mouse prostate (TRAMP) mice. The ability of 1 to promote resistance to radiation was also analyzed by using an inhibitory antibody to 1, AIIB2, in a xenograft model. The role of 1 integrins and of a 1 downstream target, c-Jun amino-terminal kinase 1 (JNK1), in regulating radiation-induced apoptosis in vivo and in vitro was studied. We show that 1 integrins promote prostate cancer (PrCa) progression and resistance to radiation in vivo. Mechanistically, 1 integrins are shown here to suppress activation of JNK1 and, consequently apoptosis, in response to irradiation. Downregulation of JNK1 is necessary to preserve the effect of 1 on resistance to radiation in vitro and in vivo. Finally, given the established crosstalk between 1 integrins and type1 insulin-like growth factor receptor (IGF-IR), we analyzed the ability of IGF-IR to modulate 1 integrin levels. We report that IGF-IR regulates the expression of 1 integrins, which in turn confer resistance to radiation in PrCa cells. In conclusion, this study demonstrates that 1 integrins mediate resistance to ionizing radiation through inhibition of JNK1 activation. J. Cell. Physiol. 228: 16011609, 2013. (c) 2013 Wiley Periodicals, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据